 |
| Attached files |
| File | Filename |
|---|
| EX-32.01 - CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - CHINA PEDIATRIC PHARMACEUTICALS, INC. | exhibit_32-1.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R50.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R47.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R20.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R38.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R27.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R58.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R10.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R5.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R41.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R49.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R26.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R21.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R51.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R34.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R16.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R14.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R13.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R60.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R15.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R19.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R23.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R11.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R12.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R4.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R18.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R1.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R17.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R3.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R7.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R24.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R36.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R22.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R35.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R59.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R6.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R45.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R2.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R53.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R40.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R32.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R8.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R31.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R30.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R44.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R56.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R28.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R29.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R43.htm |
| EXCEL - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R9.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R52.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R37.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R25.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R57.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R33.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R46.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R55.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R48.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R54.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R39.htm |
| EX-31.02 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - CHINA PEDIATRIC PHARMACEUTICALS, INC. | exhibit_31-2.htm |
| EX-31.01 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - CHINA PEDIATRIC PHARMACEUTICALS, INC. | exhibit_31-1.htm |
| 10-Q - SEPTEMBER 30, 2011 QUARTERLY REPORT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | cpdu_2012sept30-10q.htm |
v2.4.0.6
|
Property, Plant and Equipment - Property, Plant and Equipment (Details) (USD $)
|
Sep. 30, 2012
|
Dec. 31, 2011
|
| Notes to Financial Statements |
|
|
| Buildings |
$ 568,953 |
$ 566,090 |
| Plant and equipment |
1,096,697 |
1,091,178 |
| Transportation equipment |
7,158 |
7,123 |
| Office equipment |
54,922 |
54,645 |
| Total |
1,727,730 |
1,719,036 |
| Accumulated depreciation |
(915,824) |
(842,136) |
| Property, plant & equipment, net (note 6) |
$ 811,906 |
$ 876,900 |
| X |
- Details
| Name: |
CPDU_NotesToFinancialStatementsAbstract |
| Namespace Prefix: |
CPDU_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 14
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 5
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details
| Name: |
us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
credit |
| Period Type: |
instant |
|
| X |
- Definition
Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6812-107765
+ Details
| Name: |
us-gaap_BuildingsAndImprovementsGross |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
instant |
|
| X |
- Definition
Gross amount of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_PropertyPlantAndEquipmentGross |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
instant |
|
| X |
- Definition
Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 8
-Article 7
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 12
-Paragraph 5
-Subparagraph b, c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5
+ Details
| Name: |
us-gaap_PropertyPlantAndEquipmentNet |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
instant |
|
| X |
- Definition
The net amount of capitalized assets classified as property, plant and equipment not otherwise defined in the taxonomy.
+ References+ Details
| Name: |
us-gaap_PropertyPlantAndEquipmentOtherNet |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
debit |
| Period Type: |
instant |
|
This web site and associated pages are not associated with, endorsed by, or sponsored by CHINA PEDIATRIC PHARMACEUTICALS, INC. and has no official or unofficial affiliation with CHINA PEDIATRIC PHARMACEUTICALS, INC.
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
|
|
